Evidence map›Paper›PMID 23803700›Full record

Trial reportJAMA psychiatry2013

Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction.

Anna B Konova, Scott J Moeller, Dardo Tomasi, Nora D Volkow, Rita Z Goldstein

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Neural basis of adolescent THC-induced potentiation of opioid responses later in life.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  10. Review
  11. Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Anna B KonovaDepartment of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Scott J Moeller
Dardo Tomasi
Nora D Volkow
Rita Z Goldstein
Icahn School of Medicine at Mount Sinai · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institute on Drug Abuse · USStony Brook University · US

Funding

Neurobiology of Substance Abuse and AddictionZIAAA000550 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI VOLKOW, NORA D. · 2009 to 2025
$115.1M
The prefrontal cortex in salience and control in cocaine addiction: phFMRI studyR01DA023579 · NIDA · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI GOLDSTEIN, RITA Z · 2008 to 2012
$2.8M
Impaired Insight and Drug-Seeking Behavior in Cocaine Addiction: an fMRI StudyF32DA030017 · NIDA · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MOELLER, SCOTT J · 2010 to 2012
$156k
NIDA NIH HHS 1F32DA030017-01NIDA NIH HHS 1R01DA023579NIDA NIH HHS F32 DA030017NIDA NIH HHS R01 DA023579
6 · The paper itself

Abstract

importanceCocaine addiction is associated with altered resting-state functional connectivity among regions of the mesocorticolimbic dopamine pathways. Methylphenidate hydrochloride, an indirect dopamine agonist, normalizes task-related regional brain activity and associated behavior in cocaine users; however, the neural systems-level effects of methylphenidate in this population have not yet been described.

objectiveTo use resting-state functional magnetic resonance imaging to examine changes in mesocorticolimbic connectivity with methylphenidate and how connectivity of affected pathways relates to severity of cocaine addiction.

designRandomized, placebo-controlled, before-after, crossover study.

settingClinical research center.

participantsEighteen nonabstaining individuals with cocaine use disorders.

interventionsSingle doses of oral methylphenidate (20 mg) or placebo were administered at each of 2 study sessions. At each session, resting scans were acquired twice: immediately after drug administration (before the onset of effects [baseline]) and 120 minutes later (within the window of peak effects). MAIN OUTCOMES AND MEASURES: Functional connectivity strength was evaluated using a seed voxel correlation approach. Changes in this measure were examined to characterize the neural systems-level effects of methylphenidate; severity of cocaine addiction was assessed by interview and questionnaire.

resultsShort-term methylphenidate administration reduced an abnormally strong connectivity of the ventral striatum with the dorsal striatum (putamen/globus pallidus), and lower connectivity between these regions during placebo administration uniquely correlated with less severe addiction. In contrast, methylphenidate strengthened several corticolimbic and corticocortical connections. CONCLUSIONS AND RELEVANCE: These findings help elucidate the neural systems-level effects of methylphenidate and suggest that short-term methylphenidate can, at least transiently, remodel abnormal circuitry relevant to the pathophysiologic characteristics of cocaine addiction. In particular, the effects of methylphenidate within striatal and cortical pathways constitute a potentially viable mechanism by which methylphenidate could facilitate control of behavior in cocaine addiction.

Indexed as

ConnectomeAdultBrainCocaine-Related DisordersCross-Over StudiesDopamineDopamine Uptake InhibitorsFemaleHumansMagnetic Resonance ImagingMaleMembrane PotentialsMethylphenidateMiddle AgedNeural PathwaysSeverity of Illness IndexDopamineDopamine Uptake InhibitorsMethylphenidate

Identifiers

PMID23803700
PMCPMC4358734
OpenAlexW1988317442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.